Thoa Bravo has called off its potential $2 billion-plus sale of Imprivata as coronavirus-related fears continue to weigh on global markets and economies, according to people familiar with the matter. The auction for Imprivata, a healthcare-focused information security company, was shut down indefinitely at the start of last week, sources said. Indications of interest were submitted and the process’s second phase was just kicking off, according to one of the people.
Read the full article: Thoma Bravo Shuts Down Imprivata Process As Covid-19 Fears Fuel Market Volatility //
Source: https://www.pehub.com/thoma-bravo-shuts-down-imprivata-process-as-covid-19-fears-fuel-market-volatility